247 related articles for article (PubMed ID: 28370342)
21. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
Tuppurainen MT; Komulainen M; Kröger H; Honkanen R; Jurvelin J; Puntila E; Heikkinen AM; Alhava E; Saarikoski S
Osteoporos Int; 1998; 8(1):32-8. PubMed ID: 9692075
[TBL] [Abstract][Full Text] [Related]
22. Cross-sex testosterone therapy in ovariectomized mice: addition of low-dose estrogen preserves bone architecture.
Goetz TG; Mamillapalli R; Devlin MJ; Robbins AE; Majidi-Zolbin M; Taylor HS
Am J Physiol Endocrinol Metab; 2017 Nov; 313(5):E540-E551. PubMed ID: 28765273
[TBL] [Abstract][Full Text] [Related]
23. Effect of Testosterone Use on Bone Mineral Density in HIV-Infected Men.
Grant PM; Li X; Jacobson LP; Palella FJ; Kingsley LA; Margolick JB; Dobs AS; Lake JE; Althoff KN; Brown TT
AIDS Res Hum Retroviruses; 2019 Jan; 35(1):75-80. PubMed ID: 30280921
[TBL] [Abstract][Full Text] [Related]
24. Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen.
Scheres LJJ; Selier NLD; Nota NM; van Diemen JJK; Cannegieter SC; den Heijer M
J Thromb Haemost; 2021 Apr; 19(4):1029-1037. PubMed ID: 33527671
[TBL] [Abstract][Full Text] [Related]
25. Change in grip strength in trans people and its association with lean body mass and bone density.
Scharff M; Wiepjes CM; Klaver M; Schreiner T; T'Sjoen G; den Heijer M
Endocr Connect; 2019 Jul; 8(7):1020-1028. PubMed ID: 31247588
[TBL] [Abstract][Full Text] [Related]
26. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.
Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Honkanen R; Saarikoski S
Osteoporos Int; 2000; 11(3):211-8. PubMed ID: 10824236
[TBL] [Abstract][Full Text] [Related]
27. Sex steroids, biochemical markers, bone mineral density and histomorphometry in male osteoporosis patients.
Fassbender WJ; Balli M; Görtz B; Hinrichs B; Kaiser HE; Tracke HS
In Vivo; 2000; 14(5):611-8. PubMed ID: 11125545
[TBL] [Abstract][Full Text] [Related]
28. Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study.
de Blok CJM; Klaver M; Wiepjes CM; Nota NM; Heijboer AC; Fisher AD; Schreiner T; T'Sjoen G; den Heijer M
J Clin Endocrinol Metab; 2018 Feb; 103(2):532-538. PubMed ID: 29165635
[TBL] [Abstract][Full Text] [Related]
29. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN.
Sowers MR; Finkelstein JS; Ettinger B; Bondarenko I; Neer RM; Cauley JA; Sherman S; Greendale GA;
Osteoporos Int; 2003 Jan; 14(1):44-52. PubMed ID: 12577184
[TBL] [Abstract][Full Text] [Related]
30. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
[TBL] [Abstract][Full Text] [Related]
31. Gender-Affirming Hormone Treatment Induces Facial Feminization in Transwomen and Masculinization in Transmen: Quantification by 3D Scanning and Patient-Reported Outcome Measures.
Tebbens M; Nota NM; Liberton NPTJ; Meijer BA; Kreukels BPC; Forouzanfar T; Verdaasdonk RM; den Heijer M
J Sex Med; 2019 May; 16(5):746-754. PubMed ID: 30926514
[TBL] [Abstract][Full Text] [Related]
32. Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study.
Santi D; Madeo B; Carli F; Zona S; Brigante G; Vescini F; Guaraldi G; Rochira V
Osteoporos Int; 2016 Mar; 27(3):1103-1114. PubMed ID: 26510848
[TBL] [Abstract][Full Text] [Related]
33. Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men.
Gonnelli S; Cepollaro C; Gennari L; Montagnani A; Caffarelli C; Merlotti D; Rossi S; Cadirni A; Nuti R
Osteoporos Int; 2005 Aug; 16(8):963-8. PubMed ID: 15599495
[TBL] [Abstract][Full Text] [Related]
34. Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational study.
Van Caenegem E; Wierckx K; Taes Y; Schreiner T; Vandewalle S; Toye K; Kaufman JM; T'Sjoen G
Osteoporos Int; 2015 Jan; 26(1):35-47. PubMed ID: 25377496
[TBL] [Abstract][Full Text] [Related]
35. Effect of alcohol consumption on bone mineral density and hormonal parameters in physically active male soldiers.
Venkat KK; Arora MM; Singh P; Desai M; Khatkhatay I
Bone; 2009 Sep; 45(3):449-54. PubMed ID: 19450718
[TBL] [Abstract][Full Text] [Related]
36. Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data.
Ristori J; Cocchetti C; Castellini G; Pierdominici M; Cipriani A; Testi D; Gavazzi G; Mazzoli F; Mosconi M; Meriggiola MC; Cassioli E; Vignozzi L; Ricca V; Maggi M; Fisher AD
J Sex Med; 2020 Jan; 17(1):142-151. PubMed ID: 31735612
[TBL] [Abstract][Full Text] [Related]
37. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women.
Gai L; Jia Y; Zhang M; Gai P; Wang S; Shi H; Yu X; Liu Y
Contraception; 2012 Oct; 86(4):332-6. PubMed ID: 22364818
[TBL] [Abstract][Full Text] [Related]
38. Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria.
Klink D; Caris M; Heijboer A; van Trotsenburg M; Rotteveel J
J Clin Endocrinol Metab; 2015 Feb; 100(2):E270-5. PubMed ID: 25427144
[TBL] [Abstract][Full Text] [Related]
39. Effects of alendronate and calcitonin on bone mineral density in postmenopausal osteoporotic women. An observational study.
Hejdova M; Palicka V; Kucera Z; Vlcek J
Pharm World Sci; 2005 Jun; 27(3):149-53. PubMed ID: 16096879
[TBL] [Abstract][Full Text] [Related]
40. Relationship between parity and bone mass in postmenopausal women according to number of parities and age.
Heidari B; Heidari P; Nourooddini HG; Hajian-Tilaki KO
J Reprod Med; 2013; 58(9-10):389-94. PubMed ID: 24050027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
